YPEL5 and colorectal carcinoma: Our findings highlight a novel m6A regulatory mechanism, with ‘writer’ METTL3, ‘reader’ YTHDF2, and ‘target’ YPEL5 being promising diagnostic or therapeutic targets in CRC.